WOOJUNG BIO, Inc. Logo

WOOJUNG BIO, Inc.

Integrated R&D platform offering CRO services, lab construction, and biotech incubation.

215380 | KO

Overview

Corporate Details

ISIN(s):
KR7215380007
LEI:
Country:
South Korea
Address:
경기도 화성시 동탄기흥로 593-8 (영천동, 우정바이오 신약클러스터I), 화성시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

WOOJUNG BIO, Inc. is an integrated biopharmaceutical R&D solutions provider, operating as an open innovation platform for new drug development. The company's business is structured around three main pillars. Its Pre-clinical Contract Research Organization (CRO) delivers tailored services including efficacy studies, safety evaluations, and pharmaceutical analysis, utilizing its leading, AAALAC-accredited animal research facilities. The Engineering & Construction division provides comprehensive A-to-Z solutions for laboratory modernization, from design and construction of GMP facilities and clean rooms to ongoing maintenance. Additionally, its LAB CLOUD initiative functions as an R&D cluster, offering specialized labs, incubation, and acceleration support to biotech ventures and startups, facilitating the translation of innovative concepts into therapeutic applications.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 123.0 KB
2025-08-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 126.1 KB
2025-08-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-08-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-27 00:00
Major Shareholding Notification
최대주주변경
Korean 30.2 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-21 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.3 KB
2025-05-21 00:00
Board/Management Information
[기재정정]대표이사변경
Korean 14.6 KB
2025-05-16 00:00
Board/Management Information
대표이사변경
Korean 9.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 979.9 KB
2025-04-22 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-03-28 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 26.0 KB
2025-03-20 00:00
Audit Report / Information
감사보고서제출
Korean 20.0 KB
2025-03-20 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 596.0 KB
2025-03-13 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 137.5 KB

Automate Your Workflow. Get a real-time feed of all WOOJUNG BIO, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for WOOJUNG BIO, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for WOOJUNG BIO, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advancing high-grade copper and precious metal projects from discovery to production.
Canada
COR
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden
CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland
CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America
CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America
CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America
CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America
CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan
6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America
CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan
4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.